Advertisement
Canada markets open in 5 hours 35 minutes
  • S&P/TSX

    21,873.72
    -138.00 (-0.63%)
     
  • S&P 500

    5,071.63
    +1.08 (+0.02%)
     
  • DOW

    38,460.92
    -42.77 (-0.11%)
     
  • CAD/USD

    0.7313
    +0.0015 (+0.20%)
     
  • CRUDE OIL

    83.01
    +0.20 (+0.24%)
     
  • Bitcoin CAD

    87,582.15
    -3,751.25 (-4.11%)
     
  • CMC Crypto 200

    1,385.88
    +3.31 (+0.24%)
     
  • GOLD FUTURES

    2,335.10
    -3.30 (-0.14%)
     
  • RUSSELL 2000

    1,995.43
    -7.22 (-0.36%)
     
  • 10-Yr Bond

    4.6520
    +0.0540 (+1.17%)
     
  • NASDAQ futures

    17,454.25
    -210.25 (-1.19%)
     
  • VOLATILITY

    16.26
    +0.29 (+1.82%)
     
  • FTSE

    8,076.84
    +36.46 (+0.45%)
     
  • NIKKEI 225

    37,628.48
    -831.60 (-2.16%)
     
  • CAD/EUR

    0.6819
    0.0000 (0.00%)
     

Is DocuSign (DOCU) A Buy Ahead of Q1 Earnings Announcement?

Cloud-based software provider DocuSign DOCU is set to report first-quarter earnings results on Thursday after the bell. The stock has lagged other tech stocks this year, as high competition and increased expenses have kept shares under pressure.

Still, DocuSign, a Zacks Rank #5 (Strong Sell), has seen buyers return ahead of the announcement. But given weakness this year, is DOCU a buy?

DOCU has surpassed earnings estimates in three of the past four quarters, with an average beat of 12.26% over that timeframe. The company is expected to post a Q1 profit of $0.53/share, which would translate to a 39.47% increase versus the same quarter last year. Revenues are projected to have risen 8.91% to $641.15 million during the first quarter.

Earnings estimates have been relatively stagnant as of late, with no change for the first quarter in over 60 days. DocuSign stock remains relatively overvalued compared to its industry group. Despite a beat during the company’s fiscal fourth quarter announcement back in March, shares plunged more than 20% the following day.

ADVERTISEMENT

Investors should proceed with caution and remember that it’s not necessarily about the results themselves, but management guidance and the market’s reaction as well.

Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report

DocuSign (DOCU) : Free Stock Analysis Report

To read this article on Zacks.com click here.

Zacks Investment Research